ISDR 已转推

Out today in @DiabetologiaJnl rdcu.be/b9M21. Individualised (personalised) variable-interval risk-based screening for #diabeticretinopathy shows good safety, improved efficacy and substantial cost savings compared to annual screening. @ISDRstudy,@StPaulsNews,@livuninews

English





















